|
June 2026 TRANSFORMING LUPUS CARE THROUGH CAR-T CELL THERAPY, TARGETED BIOLOGICS AND CLINICAL TRIALSIrene Blanco, MD, discusses promising developments in CAR‑T cell therapy, bispecific T‑cell engagers and clinical trials aimed at achieving long-term drug‑free remission. Together, these innovations underscore a shift toward more personalized, mechanism‑driven care.
|
Irene Blanco, MD, Director of Lupus Clinical Services and Professor of Rheumatology at Northwestern Medicine
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|
